Page last updated: 2024-08-22

n-methylaspartate and jtk-303

n-methylaspartate has been researched along with jtk-303 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bading, H; Bas-Orth, C; Bengtson, CP; Hagenston, AM; Merz, SF; Tepohl, C	1

Other Studies

1 other study(ies) available for n-methylaspartate and jtk-303

Article	Year
A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir. Molecular brain, 2020, 09-14, Volume: 13, Issue:1 Topics: Animals; Antiviral Agents; Cell Death; Cells, Cultured; Channelrhodopsins; Drug Approval; Excitatory Postsynaptic Potentials; HEK293 Cells; Humans; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Microscopy; N-Methylaspartate; Neurons; Neuroprotection; Neuroprotective Agents; Optogenetics; Quinolones; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Small Molecule Libraries; Synapses; United States; United States Food and Drug Administration	2020

Article

Year

A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir.

Molecular brain, 2020, 09-14, Volume: 13, Issue:1

Topics: Animals; Antiviral Agents; Cell Death; Cells, Cultured; Channelrhodopsins; Drug Approval; Excitatory Postsynaptic Potentials; HEK293 Cells; Humans; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Microscopy; N-Methylaspartate; Neurons; Neuroprotection; Neuroprotective Agents; Optogenetics; Quinolones; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Small Molecule Libraries; Synapses; United States; United States Food and Drug Administration

2020